復星系反彈 復星國際漲超5% 與北京國資委探討合作
格隆匯9月15日丨復星系連跌兩日後反彈,復星國際(0656.HK)漲超5%,復星旅遊文化(1992.HK)漲近2%,復星醫藥(2196.HK)漲0.48%。消息面上,復星集團14日拜會北京市國資委,雙方圍繞復星與北京市國有企業在醫藥健康、消費、科技、金融等領域長期以來開展的合作,以及參與國企混改工作推進情況進行了深入交流,並就未來加強合作、推動項目在北京加快落地進行了探討。另外,復星就彭博新聞社“監管部門要求摸底復星”報道嚴重失實一事,將向法院提起訴訟。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.